Anti-MVD Antibody Picoband® (Biotine Conjugate)

Catalog number A01631-1-Biotin

Price for A01631-1-Biotin

Size / count 100 µg/Vial

About this product

Boster Bio Anti-MVD Antibody Picoband® catalog # A01631-1. Tested in WB applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

Specifications

Catalog number: A01631-1-Biotin
Size / count: 100 µg/Vial
Dry ice: No
Hazardous: No
Discontinued: No
Background: The enzyme mevalonate pyrophosphate decarboxylase (MVD; EC 4.1.1.33) catalyzes the conversion of mevalonate pyrophosphate into isopentenyl pyrophosphate. This unusual enzyme decarboxylates and dehydrates its substrate while hydrolyzing ATP. As a unique enzyme in one of the early steps in cholesterol biosynthesis, MVD may be a useful target for drugs aimed at lowering serum cholesterol levels. This gene is mapped to chromosome 16q24.3 based on an alignment of the MVDsequence.
Synonyms: Diphosphomevalonate decarboxylase; Mevalonate (diphospho)decarboxylase; MDDase; Mevalonate pyrophosphate decarboxylase; MVD; MPD
Gene Name: mevalonate diphosphate decarboxylase
UniProt: P53602
Host: Rabbit
Reactivity: Human,Mouse,Rat
Cross Reactivity: No cross-reactivity with other proteins.
Immunogen: A synthetic peptide corresponding to a sequence at the N-terminus of human MVD, which shares 97.3% amino acid (aa) sequence identity with both mouse and rat MVD.
Clonality: Polyclonal
Tissue Specificity: Expressed in heart, skeletal muscle, lung, liver, brain, pancreas, kidney and placenta.
Applications: WB
Concentration: Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.
Form: Lyophilized
Reconstitution: Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Function: Performs the first committed step in the biosynthesis of isoprenes.
Storage Conditions: Store at -20℃ for one year from date of receipt. After reconstitution, at 4℃ for one month. It can also be aliquotted and stored frozen at -20℃ for six months. Avoid repeated freeze-thaw cycles.
Fragment: Rabbit IgG
Applications Notes: Western blot, 0.1-0.5μg/ml<br>

Frequently Asked Questions

What is the catalog number for Anti-MVD Antibody Picoband® (Biotine Conjugate)?

The catalog number for Anti-MVD Antibody Picoband® (Biotine Conjugate) is A01631-1-Biotin.

What sizes are available for Anti-MVD Antibody Picoband® (Biotine Conjugate)?

Anti-MVD Antibody Picoband® (Biotine Conjugate) is available in the following size(s): 100 µg/Vial.

Is Anti-MVD Antibody Picoband® (Biotine Conjugate) in stock?

Anti-MVD Antibody Picoband® (Biotine Conjugate) is currently made to order / not held in immediate stock. Contact us for lead time.

Where can I find the safety data sheet (SDS/MSDS) for Anti-MVD Antibody Picoband® (Biotine Conjugate)?

The safety data sheet for Anti-MVD Antibody Picoband® (Biotine Conjugate) is available here: https://www.bosterbio.com/msds?sku=A01631-1.

What is Anti-MVD Antibody Picoband® (Biotine Conjugate) used for?

What is the shelf life of this product?

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

What expression system was used for this recombinant protein?

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Can I return this product if I ordered the wrong one?

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.